403 related articles for article (PubMed ID: 28066979)
1. When proteostasis goes bad: Protein aggregation in the cell.
Radwan M; Wood RJ; Sui X; Hatters DM
IUBMB Life; 2017 Feb; 69(2):49-54. PubMed ID: 28066979
[TBL] [Abstract][Full Text] [Related]
2. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
[TBL] [Abstract][Full Text] [Related]
3. Challenging Proteostasis: Role of the Chaperone Network to Control Aggregation-Prone Proteins in Human Disease.
Sinnige T; Yu A; Morimoto RI
Adv Exp Med Biol; 2020; 1243():53-68. PubMed ID: 32297211
[TBL] [Abstract][Full Text] [Related]
4. In vivo aspects of protein folding and quality control.
Balchin D; Hayer-Hartl M; Hartl FU
Science; 2016 Jul; 353(6294):aac4354. PubMed ID: 27365453
[TBL] [Abstract][Full Text] [Related]
5. Walking the tightrope: proteostasis and neurodegenerative disease.
Yerbury JJ; Ooi L; Dillin A; Saunders DN; Hatters DM; Beart PM; Cashman NR; Wilson MR; Ecroyd H
J Neurochem; 2016 May; 137(4):489-505. PubMed ID: 26872075
[TBL] [Abstract][Full Text] [Related]
6. Mechanisms and Functions of Spatial Protein Quality Control.
Sontag EM; Samant RS; Frydman J
Annu Rev Biochem; 2017 Jun; 86():97-122. PubMed ID: 28489421
[TBL] [Abstract][Full Text] [Related]
7. Protein aggregation and ER stress.
Ogen-Shtern N; Ben David T; Lederkremer GZ
Brain Res; 2016 Oct; 1648(Pt B):658-666. PubMed ID: 27037184
[TBL] [Abstract][Full Text] [Related]
8. Molecular chaperones biochemistry and role in neurodegenerative diseases.
Chaari A
Int J Biol Macromol; 2019 Jun; 131():396-411. PubMed ID: 30853582
[TBL] [Abstract][Full Text] [Related]
9. Protein folding, misfolding and quality control: the role of molecular chaperones.
Papsdorf K; Richter K
Essays Biochem; 2014; 56():53-68. PubMed ID: 25131586
[TBL] [Abstract][Full Text] [Related]
10. Proteostasis impairment in protein-misfolding and -aggregation diseases.
Hipp MS; Park SH; Hartl FU
Trends Cell Biol; 2014 Sep; 24(9):506-14. PubMed ID: 24946960
[TBL] [Abstract][Full Text] [Related]
11. Protein aggregation in cell biology: An aggregomics perspective of health and disease.
Cox D; Raeburn C; Sui X; Hatters DM
Semin Cell Dev Biol; 2020 Mar; 99():40-54. PubMed ID: 29753879
[TBL] [Abstract][Full Text] [Related]
12. Posttranslational modifications and proteinopathies: how guardians of the proteome are defeated.
Olzscha H
Biol Chem; 2019 Jun; 400(7):895-915. PubMed ID: 30998500
[TBL] [Abstract][Full Text] [Related]
13. The intrinsic and extrinsic factors that contribute to proteostasis decline and pathological protein misfolding.
Kikis EA
Adv Protein Chem Struct Biol; 2019; 118():145-161. PubMed ID: 31928724
[TBL] [Abstract][Full Text] [Related]
14. Protein folding, misfolding and aggregation: A tale of constructive to destructive assembly.
Khan MV; Zakariya SM; Khan RH
Int J Biol Macromol; 2018 Jun; 112():217-229. PubMed ID: 29374532
[TBL] [Abstract][Full Text] [Related]
15. Defective protein folding and aggregation as the basis of neurodegenerative diseases: the darker aspect of proteins.
Naeem A; Fazili NA
Cell Biochem Biophys; 2011 Nov; 61(2):237-50. PubMed ID: 21573992
[TBL] [Abstract][Full Text] [Related]
16. A chaperome subnetwork safeguards proteostasis in aging and neurodegenerative disease.
Brehme M; Voisine C; Rolland T; Wachi S; Soper JH; Zhu Y; Orton K; Villella A; Garza D; Vidal M; Ge H; Morimoto RI
Cell Rep; 2014 Nov; 9(3):1135-50. PubMed ID: 25437566
[TBL] [Abstract][Full Text] [Related]
17. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
Victoria GS; Zurzolo C
J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
[TBL] [Abstract][Full Text] [Related]
18. Proteomic analysis of protein homeostasis and aggregation.
Laskowska E; Kuczyńska-Wiśnik D; Lipińska B
J Proteomics; 2019 Apr; 198():98-112. PubMed ID: 30529741
[TBL] [Abstract][Full Text] [Related]
19. Protein-misfolding diseases and chaperone-based therapeutic approaches.
Chaudhuri TK; Paul S
FEBS J; 2006 Apr; 273(7):1331-49. PubMed ID: 16689923
[TBL] [Abstract][Full Text] [Related]
20. Pathways of cellular proteostasis in aging and disease.
Klaips CL; Jayaraj GG; Hartl FU
J Cell Biol; 2018 Jan; 217(1):51-63. PubMed ID: 29127110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
